Sponsors (3)
The bill speeds access to markets, strengthens rapid data sharing and removal of dangerous imports, and offers procedural protections for some importers, but it shifts oversight and confidentiality responsibilities toward third‑party auditors and subnational authorities—raising risks of inconsistent audits, privacy/commercial exposure, added costs for small businesses, and potential overbroad destruction authority.
State, local, Tribal, and territorial health authorities (and thereby the public) get faster, more complete FDA lab/inspection/distribution data and limited disclosure authority during incidents, enabling quicker detection of outbreaks and more targeted, faster recalls that reduce consumer illness.
HHS can immediately destroy refused imported food/drugs that present a significant public‑health risk, allowing faster removal of dangerous products from commerce and lowering public‑health exposure.
FDA can use accredited third‑party audit results to better target inspections and prioritize higher‑risk products, improving oversight efficiency and allowing FDA enforcement resources to focus where risks are greatest.
Consumers and patients face increased risk if FDA relies on third‑party certifications for program eligibility or oversight, because inconsistent audit quality or weak accreditation oversight could create gaps in food‑ and drug‑safety protection.
Sharing unredacted FDA data with subnational authorities raises privacy and confidentiality risks for individuals and businesses if safeguards or redaction standards are inadequate.
Disclosure of commercially protected federal information to subnational authorities risks revealing trade secrets or business‑sensitive data, which could harm companies' competitive positions and lead to economic losses.
Based on analysis of 4 sections of legislative text.
Broadens third‑party food audits to include domestic facilities, authorizes unredacted FDA data sharing with public‑health authorities, and lets HHS order destruction of refused imports posing significant public‑health risks.
Official title: Amend the Federal Food, Drug, and Cosmetic Act with respect to food safety.
Introduced July 14, 2026 by Thomas Hawley Tuberville · Last progress July 14, 2026
Expands FDA authority to use accredited third‑party audits more broadly, lets FDA share unredacted food‑safety data with State, local, Tribal, and territorial public‑health counterparts, and gives HHS/FDA the power to order destruction (without export) of imported articles previously refused admission when they pose a significant public‑health concern. The bill updates who can be audited and how certifications may be used, sets procedural protections for destruction orders, and requires rulemaking timelines for implementation.